The death of journalist Vladimir Matijanić from Covid-19 raised questions about the adequacy of the health system in Croatia, and also led to a fresh wave of criticism of Health Minister Vili Beroš

The Chinese company producing Azvudone claimed that 40% of COVID-19 patients administered the drug for more than a week during the third phase of the clinical trial showed improvements when it came to symptoms

The drug candidates for repurposing are imatinib, a cancer drug; infliximab, an antibody; and artesunate, an anti-malarial drug. The tests seek to explore possible drugs that can be repurposed to treat severely affected COVID-19 patients

Immunologist Dr. Satyajit Rath analyses the current COVID-19 crisis in India with Newsclick editor-in-chief Prabir Purkayastha.

In tackling the second wave, India’s Central government led by Narendra Modi has been bumbling and groping for solutions, mostly much delayed and inadequate

None of the four drug/drug combinations that were deployed in the WHO’s SOLIDARITY trial were found to be effective in reducing mortality, not even the much-hyped anti-viral drug Remdesivir

After making America sick again, president Donald Trump is trying to compensate for his administration’s failure by buying up the entire stock of Remdesivir from Gilead for the next three months for the US, and leaving nothing for the rest of the world.

Trump is trying to improve his waning electoral chances by reserving all of Gilead’s stock of Remdesivir to cover up his disastrous handling of the Covid-19 epidemic so far

Newsclick’s Prabir Purkayastha discusses the US buying out supplies of the COVID-19 drug, Remdesivir.

In a trial, Dexamethasone, an inexpensive and widely used corticosteroid, reduced deaths by one-third in ventilated patients and by one-fifth in patients receiving oxygen support

Activists of the People’s Health Movement talk about the World Health Assembly that begins today, the key issues that will come up for discussion, and the collapse of the global governance system in the realm of public health

A group of Chinese researchers have successfully decoded the structure of the viral enzyme key to the novel coronavirus’ survival